CG Oncology, Inc. (CGON) stock
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$78.94−5.84 (-6.89%)
Close on Nov 17, 2026Market cap $7.00BP/E –Yield –
CG Oncology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
CG Oncology's price to book ratio was 6.2× on Nov 11, 2026, against 5.1× a year earlier. Over the last 3 years it ranged from 2.5× to 7.3×, with a median of 4.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.2× | +1.5 |
| 2025 | Dec 31, 2025 | 4.7× | +1.1 |
| 2024 | Dec 31, 2024 | 3.6× | – |
See a number that looks wrong?